Although the PSA test detects an increased risk of prostate cancer at an early stage of the disease, it has low specificity (7) such that most men with an elevated PSA either do not have prostate cancer or have low-risk disease that is unlikely to affect quality or length of life if left untreated. The gene discussed is KLK3; the disease is prostate carcinoma.